Mr Walbert is currently president and CEO of IDM Pharma. Prior to IDM Pharma, Mr Walbert served as executive vice president of commercial operations at NeoPharm.
George Tidmarsh, founder, scientific consultant and board member of Horizon, said: “Tim has the perfect background to lead our company as we move toward the unblinding of the Phase III clinical data for our lead product candidate HZT-501, a proprietary formulation of ibuprofen combined with famotidine in a single pill. We are thrilled to have someone of his caliber joining Horizon.”